IP Library Granted Patent US 8,734,527
Granted Patent B2
US 8,734,527 · App. 12/337,413 · Granted May 27, 2014

Encapsulated kidney tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,734,527
App. No.
12/337,413
Granted
May 27, 2014
Kind
B2
Abstract

Provided are therapeutic implants comprising renal tissue encapsulated within a polymer bead. Also disclosed are methods for treating a disease state in a subject comprising implanting within said subject a therapeutic implant comprising renal tissue encapsulated within a polymer bead. Also provided are methods for making a therapeutic implant comprising: providing renal tissue; mixing the renal tissue with a solution comprising a polymer, thereby forming a tissue-polymer suspension; extruding the tissue-polymer suspension into an bead-forming solution, thereby forming a therapeutic implant comprising beads of said polymer within which the renal tissue is encapsulated.

Claims (21)

1. A therapeutic implant comprising excised and minced fragments of whole renal tissue having a size of less than 1 mm, encapsulated in the presence of a growth medium within a polymer bead that is permeable to substances secreted by said tissue.

2. The therapeutic implant according to claim 1 , wherein said renal tissue is autologous tissue, allogeneic tissue, xenogeneic tissue, or any combination thereof.

3. The therapeutic implant according to claim 1 , wherein said fragments of excised and minced whole renal tissue have a size of less than about 300 μm.

4. The therapeutic implant according to claim 1 , comprising at least about 30 mg of renal tissue.

5. The therapeutic implant according to claim 1 , wherein said polymer bead comprises alginate, hyaluronic acid, carboxymethylcellulose, polyethylene glycol, dextran, agarose, poly-L-lysine, carageenan, pectin, tragacanth gum, xanthan gum, guar gum, gum arabic, type I collagen, laminin, fibronectin, fibrin, or any combination thereof.

6. The therapeutic implant according to claim 1 , wherein said polymer bead comprises alginate and poly-L-lysine.

7. The therapeutic implant according to claim 1 , wherein said polymer bead has a diameter of about 3 mm to about 6 mm.

8. The therapeutic implant according to claim 1 , wherein said excised and minced renal tissue fragments secrete one or more hormones, prohormones, proteins, growth factors, or any combination thereof.

9. The therapeutic implant according to claim 8 , wherein said renal tissue fragments secrete one or more of erythropoietin, MCP-1, adiponectin, leptin, and MMP-2.

10. A method for making a therapeutic implant comprising:

providing fragments of excised and minced whole renal tissue having a size of less than 1 mm;

mixing said fragments of excised and minced whole renal tissue with a solution comprising a first polymer and a growth medium, thereby forming a tissue-polymer suspension;

extruding said tissue-polymer suspension into a bead-forming solution, thereby forming a therapeutic implant comprising beads of said polymer within which said fragments of excised and minced whole renal tissue and growth medium are encapsulated.

11. The method according to claim 10 , wherein said first polymer is selected from the group consisting of alginate, hyaluronic acid, carboxymethylcellulose, polyethylene glycol, dextran, agarose, poly-L-lysine, carageenan, pectin, tragacanth gum, xanthan gum, guar gum, gum arabic, type I collagen, laminin, fibronectin, fibrin, or any combination thereof.

12. The method according to claim 10 , wherein said bead-forming solution comprises a cross-linking solution.

13. The method according to claim 10 , wherein said bead-forming solution comprises an ionic solution.

14. The method according to claim 10 , wherein said bead-forming solution comprises CaCl 2 .

15. The method according to claim 10 , further comprising coating said beads with an additional polymer layer.

16. The method according to claim 10 , further comprising cross-linking said polymer beads by introducing said polymer beads into a cross-linking solution containing a second polymer.

17. The method of claim 16 , wherein said first polymer is alginate and said second polymer is poly-L-lysine.

18. The method of claim 15 , wherein said additional polymer layer comprises alginate.

Assignments (8)
MERGER Recorded Nov 24, 2015
From: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC
To: DEPUY ORTHOPAEDICS, INC.
Reel/Frame 037131/0410 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2015
From: DEPUY ORTHOPAEDICS, INC.
To: DEPUY SPINE, INC.
Reel/Frame 037131/0472 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2015
From: DEPUY SPINE, LLC
To: HAND INNOVATIONS LLC
Reel/Frame 037131/0551 →
CHANGE OF NAME Recorded Nov 24, 2015
From: DEPUY SPINE, INC.
To: DEPUY SPINE, LLC
Reel/Frame 037155/0854 →
CHANGE OF NAME Recorded Nov 24, 2015
From: HAND INNOVATIONS LLC
To: DEPUY SYNTHES PRODUCTS, LLC
Reel/Frame 037156/0127 →
CHANGE OF NAME Recorded Nov 24, 2015
From: DEPUY SYNTHES PRODUCTS, LLC
To: DEPUY SYNTHES PRODUCTS, INC.
Reel/Frame 037156/0304 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2011
From: ETHICON, INCORPORATED
To: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC
Reel/Frame 026291/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2009
From: BUENSUCESO, CHARITO S.; COLTER, DAVID C.; KRAMER, BRIAN C.; SEYDA, AGNIESZKA
To: ETHICON, INCORPORATED
Reel/Frame 022326/0429 →